NAVIDEA BIOPHARMACEUTICALS, INC. 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed May 31, 2017
Insider Transaction Report
Form 4
Latkin Jed
DirectorCEO, COO & CFO
Transactions
- Purchase
Common Stock, $.001 par value
2017-05-30$0.44/sh+7,600$3,317→ 50,159 total
Signature
/s/ Jed A. Latkin|2017-05-31